January: TAG's Gregg Gonsalves becomes GMHC Director of Treatment Policy. Completion of STI Workshop 2000 report. FDA hearing on salvage therapy trial design. Merck meeting on promising DNA/adenovirus HIV vaccine. TAG mobilizes 600 signatures on global letter to Glaxo decrying…
Tissue T-Cell Analysis Represents Renewed Challenge to "Tap and Drain" Orthodoxy By Richard Jefferys Most Comprehensive Analysis One of the central tenets of HIV pathogenesis is that the virus causes a slow but progressive decline in CD4 T-cell counts. This…
Yokohama, Vancouver, Twin Pacific Ports, Serve as Polar Opposites for Scientific Advances By David Barr Everything About to Change In a September 1996 report for the Washington Post, science writer Elizabeth Kastor observed, "Hope is a hungry thing, as easily…
VaxGen's Claims of Efficacy in Black and Asian Participants Are Misleading and Premature 24 February 2003The undersigned community-based HIV/AIDS organizations are deeply concerned by today's presentation of data from the phase III clinical trial of VaxGen's HIV vaccine candidate, AIDSVAX…
AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close "Non-White Non-Hispanic" "Black" N= 498 314 Infections, vaccine group 17 12* Infections, placebo group 9 4† *p= 0.01, CI= 30-84% †p=0.02, CI= 29-93%
January: NIH workshops on long term effectiveness research, studies designed to look at "when to start" and switch HAART, and for long-term side effects. TAG hires Yvette Delph as new Antiviral Project Director. Completion of TAG's AIDS Vaccine Research at…
Critical Issues From TAG's Forthcoming HCV/HIV Co-Infection Report and Analysis By Tracy Swan Research Still Lags Tracy Swan's teaser sneak preview of her upcoming Hepatitis C/HIV Co-infection Report (Version 2.0), slated for release this spring, is now available as both…
The Boston AIDS Conference That Never Was -- And Other Grim Tales By David Barr A Sick Lymph Node Makes Its Début TAGline catches up with its peripatetic international scribe as he negotiates a perilous course around canals and through…
January: amfAR's Paul Corser dies after a nine-year struggle with AIDS. FDA approves Glaxo's atovaquone (Mepron) for the prevention of PCP pneumonia. ACT UP/Needle Exchange activist Rod Sorge dies. Retrovirus conference, Chicago. Beatrice Hahn presents on the HIV-1's chimp origins;…
Storming Montréal's Palais de Congrès, and Makeshift Battle Stations in Fortress San Francisco By David Barr Bodyguarded Investigators It could be said that NIH-activist relations reached their untenable nadir in 1990. Nearly 30,000 Americans had died of AIDS the previous…